{"transactions":[{"id":1634113,"issuer":{"id":9881,"kind":"organization","name":"LianBio"},"owners":[{"id":94133,"kind":"person","name":"Silbermann Susan Michele","position":1,"cik":"0001887214","reported_name":"Silbermann Susan Michele","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-20T21:10:42.000Z","date":"2024-02-15","kind":"exercise","planned":false,"acquired":false,"shares":36300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option became exercisable in full on June 23, 2023."}],"balance_after":0,"derivative":{"exercise_price":2.52,"expiration_date":"2032-06-23","underlying":"Ordinary Shares","underlying_shares":36300},"source":{"system":"sec-edgar","filing":"0001831283-24-000010","document":"wk-form4_1708463411.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831283/000183128324000010/wk-form4_1708463411.xml","form_type":"4"}},{"id":1634112,"issuer":{"id":9881,"kind":"organization","name":"LianBio"},"owners":[{"id":94133,"kind":"person","name":"Silbermann Susan Michele","position":1,"cik":"0001887214","reported_name":"Silbermann Susan Michele","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-02-20T21:10:42.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":19218,"price":4.76,"value":91477.68,"ownership":{"direct":true},"balance_after":17082,"source":{"system":"sec-edgar","filing":"0001831283-24-000010","document":"wk-form4_1708463411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831283/000183128324000010/wk-form4_1708463411.xml","form_type":"4"}},{"id":1634111,"issuer":{"id":9881,"kind":"organization","name":"LianBio"},"owners":[{"id":94133,"kind":"person","name":"Silbermann Susan Michele","position":1,"cik":"0001887214","reported_name":"Silbermann Susan Michele","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-02-20T21:10:42.000Z","date":"2024-02-15","kind":"exercise","planned":false,"acquired":true,"shares":36300,"price":2.52,"value":91476.0,"ownership":{"direct":true},"balance_after":36300,"source":{"system":"sec-edgar","filing":"0001831283-24-000010","document":"wk-form4_1708463411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831283/000183128324000010/wk-form4_1708463411.xml","form_type":"4"}},{"id":1738662,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":94133,"kind":"person","name":"Silbermann Susan Michele","position":1,"cik":"0001887214","reported_name":"Silbermann Susan Michele","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-11-16T21:13:02.000Z","date":"2023-11-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 28, 2023, Mallinckrodt plc (the \"Company\") and certain of its subsidiaries voluntarily initiated proceedings under chapter 11 of title 11 of the United States Code in the U.S. Bankruptcy Court for the District of Delaware (the \"Bankruptcy Court\"). On September 20, 2023, the Company's directors presented a petition before the High Court of Ireland (the \"Irish High Court\") seeking the appointment of an examiner (the \"Examiner\") to the Company, thereby commencing examinership proceedings with respect to the Company in Ireland."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 10, 2023, the Bankruptcy Court entered an order confirming the First Amended Prepackaged Joint Chapter 11 Plan of Reorganization of Mallinckrodt Plc and Its Debtor Affiliates (as may be amended or supplemented from time to time in accordance with its terms, the \"Plan\"). On November 10, 2023, the Irish High Court made an order confirming a scheme of arrangement proposed by the Examiner that is based on and consistent in all respects with the Plan (the \"Scheme\"). On November 14, 2023 (the \"Effective Date\"), the Plan and the Scheme became effective and the Company emerged from bankruptcy."},{"field":"kind","element":"transactionCoding","label":"F3","text":"On the Effective Date, all of the Company's previously outstanding ordinary shares (the \"Ordinary Shares\"), including options, warrants, rights, restricted stock units or other securities or agreements to acquire such Ordinary Shares, were cancelled and extinguished pursuant to the Plan and the Scheme. In connection with emergence, the reporting person ceased to be a Section 16 reporting person. This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-23-119112","document":"tm2330745-15_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465923119112/tm2330745-15_4seq1.xml","form_type":"4"}},{"id":1841818,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":94133,"kind":"person","name":"Silbermann Susan Michele","position":1,"cik":"0001887214","reported_name":"Silbermann Susan Michele","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-29T22:51:21.000Z","date":"2023-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":26277,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (the \"RSUs\") granted to the reporting person on January 3, 2023 were canceled by mutual agreement of the reporting person and Mallinckrodt plc (\"Mallinckrodt\") in connection with the Board of Directors (the \"Board\") of Mallinckrodt's approval of changes to the compensation of non-employee members of the Board (such changes, the \"Compensation Changes\"). In connection with the Compensation Changes, and in consideration of the cancelation of the RSUs, the reporting person will receive (i) in the event of a bankruptcy filing, additional cash compensation for 2023 of $210,000 or (ii) in the absence of a bankruptcy filing, additional cash compensation for 2023 of $245,000. In either event, the amounts are to be prepaid pro rata on a quarterly basis and paid in arrears for the prior quarters of fiscal year 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units (the \"RSUs\") granted to the reporting person on January 3, 2023 were canceled by mutual agreement of the reporting person and Mallinckrodt plc (\"Mallinckrodt\") in connection with the Board of Directors (the \"Board\") of Mallinckrodt's approval of changes to the compensation of non-employee members of the Board (such changes, the \"Compensation Changes\"). In connection with the Compensation Changes, and in consideration of the cancelation of the RSUs, the reporting person will receive (i) in the event of a bankruptcy filing, additional cash compensation for 2023 of $210,000 or (ii) in the absence of a bankruptcy filing, additional cash compensation for 2023 of $245,000. In either event, the amounts are to be prepaid pro rata on a quarterly basis and paid in arrears for the prior quarters of fiscal year 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The restricted stock units (the \"RSUs\") granted to the reporting person on January 3, 2023 were canceled by mutual agreement of the reporting person and Mallinckrodt plc (\"Mallinckrodt\") in connection with the Board of Directors (the \"Board\") of Mallinckrodt's approval of changes to the compensation of non-employee members of the Board (such changes, the \"Compensation Changes\"). In connection with the Compensation Changes, and in consideration of the cancelation of the RSUs, the reporting person will receive (i) in the event of a bankruptcy filing, additional cash compensation for 2023 of $210,000 or (ii) in the absence of a bankruptcy filing, additional cash compensation for 2023 of $245,000. In either event, the amounts are to be prepaid pro rata on a quarterly basis and paid in arrears for the prior quarters of fiscal year 2023."}],"balance_after":23122,"source":{"system":"sec-edgar","filing":"0001104659-23-076466","document":"tm2320181-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465923076466/tm2320181-7_4seq1.xml","form_type":"4"}},{"id":1841817,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":94133,"kind":"person","name":"Silbermann Susan Michele","position":1,"cik":"0001887214","reported_name":"Silbermann Susan Michele","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-29T22:51:21.000Z","date":"2023-06-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":3154,"price":1.28,"value":4037.12,"ownership":{"direct":true},"balance_after":49399,"source":{"system":"sec-edgar","filing":"0001104659-23-076466","document":"tm2320181-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465923076466/tm2320181-7_4seq1.xml","form_type":"4"}},{"id":1845385,"issuer":{"id":9881,"kind":"organization","name":"LianBio"},"owners":[{"id":94133,"kind":"person","name":"Silbermann Susan Michele","position":1,"cik":"0001887214","reported_name":"Silbermann Susan Michele","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-23T20:20:09.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":36300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest and become exercisable in full on June 21, 2024, the first anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer through such date."}],"balance_after":36300,"derivative":{"exercise_price":2.4,"expiration_date":"2033-06-21","underlying":"Ordinary Shares","underlying_shares":36300},"source":{"system":"sec-edgar","filing":"0001831283-23-000093","document":"wk-form4_1687551598.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831283/000183128323000093/wk-form4_1687551598.xml","form_type":"4"}},{"id":2061747,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":94133,"kind":"person","name":"Silbermann Susan Michele","position":1,"cik":"0001887214","reported_name":"Silbermann Susan Michele","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-01-05T23:02:13.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":26277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported ordinary shares represent restricted stock units (\"RSUs\"), which will be settled in an equal number of MNK ordinary shares and will vest ratably on each of the first two anniversaries of MNK's emergence from Chapter 11 proceedings on June 16, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person has reported prior awards of RSUs in Table II of Form 4. The total reported in Column 5 includes the 26,277 newly awarded RSUs and 26,276 RSUs previously reported in Table II."}],"balance_after":52553,"source":{"system":"sec-edgar","filing":"0001104659-23-001544","document":"tm231710-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465923001544/tm231710-5_4seq1.xml","form_type":"4"}},{"id":2138125,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":94133,"kind":"person","name":"Silbermann Susan Michele","position":1,"cik":"0001887214","reported_name":"Silbermann Susan Michele","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-10-12T12:33:00.000Z","date":"2022-10-11","kind":"grant","acquired":true,"shares":26276,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 11, 2022, Susan Silbermann received a grant of 26,276 restricted stock units (\"RSUs\"), which grant of RSUs will vest ratably on each of the first two anniversaries of Mallinckrodt plc's emergence from Chapter 11 proceedings on June 16, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 11, 2022, Susan Silbermann received a grant of 26,276 restricted stock units (\"RSUs\"), which grant of RSUs will vest ratably on each of the first two anniversaries of Mallinckrodt plc's emergence from Chapter 11 proceedings on June 16, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 11, 2022, Susan Silbermann received a grant of 26,276 restricted stock units (\"RSUs\"), which grant of RSUs will vest ratably on each of the first two anniversaries of Mallinckrodt plc's emergence from Chapter 11 proceedings on June 16, 2022."}],"balance_after":26276,"derivative":{"underlying":"Ordinary Shares","underlying_shares":26276},"source":{"system":"sec-edgar","filing":"0001104659-22-107932","document":"tm2228042-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465922107932/tm2228042-1_4seq1.xml","form_type":"4"}},{"id":2175674,"issuer":{"id":75097,"kind":"organization","name":"HilleVax, Inc.","symbol":"HLVX"},"owners":[{"id":94133,"kind":"person","name":"Silbermann Susan Michele","position":1,"cik":"0001887214","reported_name":"Silbermann Susan Michele","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-08-23T16:35:55.000Z","date":"2022-08-19","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on the first anniversary of the date of grant, subject to reporting person's continuing in service on the registrant's board of directors through such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":12.38,"expiration_date":"2032-08-18","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-22-029531","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1887214/000089924322029531/doc4.xml","form_type":"4"}},{"id":2221315,"issuer":{"id":9881,"kind":"organization","name":"LianBio"},"owners":[{"id":94133,"kind":"person","name":"Silbermann Susan Michele","position":1,"cik":"0001887214","reported_name":"Silbermann Susan Michele","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-27T20:17:36.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":36300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest and become exercisable in full on June 23, 2023, the first anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer through such date."}],"balance_after":36300,"derivative":{"exercise_price":2.52,"expiration_date":"2032-06-23","underlying":"Ordinary Shares","underlying_shares":36300},"source":{"system":"sec-edgar","filing":"0001831283-22-000049","document":"wf-form4_165636102658025.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831283/000183128322000049/wf-form4_165636102658025.xml","form_type":"4"}},{"id":2530827,"issuer":{"id":9881,"kind":"organization","name":"LianBio"},"owners":[{"id":94133,"kind":"person","name":"Silbermann Susan Michele","position":1,"cik":"0001887214","reported_name":"Silbermann Susan Michele","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-01T23:24:02.000Z","date":"2021-10-31","kind":"grant","acquired":true,"shares":72600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36 of the shares underlying the option vested and became exercisable on October 31, 2021; the remainder shall vest and become exercisable in 35 equal monthly installments such that the option shall be fully vested on October 31, 2024, subject to the Reporting Person providing continuous service to the Issuer on each such date."}],"balance_after":72600,"derivative":{"exercise_price":16,"expiration_date":"2031-10-31","underlying":"Ordinary Shares","underlying_shares":72600},"source":{"system":"sec-edgar","filing":"0000899243-21-042219","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831283/000089924321042219/doc4.xml","form_type":"4"}}]}